#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Philadelphia positive chronic myeloid leukaemia B-cell type acute leukaemia Pyruvate kinase deficiency anaemia Lymphatic malformation Canavan disease Acute lymphocytic leukaemia recurrent Metastatic malignant melanoma Cerebral amyloid angiopathy Factor IX deficiency Systemic sclerosis pulmonary Primary amyloidosis Diffuse large B-cell lymphoma recurrent Meningococcal immunisation Burkitt's lymphoma refractory Acute on chronic liver failure More trials…

    Learn about Rare Diseases

    Glycogen storage disease type I – Diagnostics Wolfram syndrome – Life with Disease Haemophilia A with anti factor VIII – Life with Disease Stevens-Johnson syndrome – Basic Information Inclusion body myositis – Treatment Shprintzen-Goldberg syndrome – Life with Disease Rosai-Dorfman syndrome – Diagnostics Medulloblastoma recurrent – Treatment Alexander disease – Basic Information Primary mediastinal large B-cell lymphoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    AB521 Napabucasin Ly3437943 Sodium Ampicillin Bi 706321 Deutivacaftor Sodium Lactate Solution FIBRIN Desoximetasone Erdafitinib Larotrectinib Sulfate IMELASOMERAN Lutetium (177Lu) Oxodotreotide Tocotrienol Abrocitinib Nemolizumab Clopidogrel Natalizumab Spesolimab Elacestrant Dihydrochloride More therapies…

    Learn about Your Condition

    Glomerulonephritis chronic Exfoliation glaucoma Spina bifida Radiation skin injury Trisomy 21 Ligament operation Large cell lung cancer Dengue fever Actinic keratosis Giardiasis Seasonal allergy Advanced systemic mastocytosis Hepato-lenticular degeneration Corticobasal degeneration Immune-mediated enterocolitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Female Urogenital Diseases and Pregnancy Complications

  • Study on Cabergoline for Pain and Fertility in Women with Endometriosis and Infertility

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Endometriosis
    Investigated Drugs:
    • Cabergoline
    Finland

  • Study on Renaparin for Improving Kidney Function in Transplant Patients with End-Stage Renal Disease from Deceased Donors

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • Corline Heparin Conjugate
    Austria Germany

  • Study on Progesterone and Estradiol for Infertility in Patients Undergoing Hormone Replacement Therapy with Frozen Embryo Transfer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Infertility
    Investigated Drugs:
    • Estradiol
    • Progesterone Ph. Eur.
    Denmark

  • Study on Renaparin for Improving Kidney Function in Patients with End-Stage Renal Disease Receiving Deceased Donor Transplants

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • Corline Heparin Conjugate
    Austria Germany

  • Study on Rituximab Treatment for Children with Complicated Steroid-Sensitive Nephrotic Syndrome

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Nephrotic syndrome
    Investigated Drugs:
    • Rituximab
    Italy

  • Study of tuvusertib combined with niraparib or lartesertib for patients with ovarian cancer that worsened after previous PARP inhibitor treatment

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Ovarian cancer
    Investigated Drugs:
    • 2-Amino-6-Fluoro-N-(5-Fluoro-4-(1-Methyl-1H-Imidazol-5-Yl)Pyridin-3-Yl)Pyrazolo[1,5-A]Pyrimidine-3-Carboxamide
    • 8-(1,3-Dimethylpyrazol-4-Yl)-1-(3-Fluoro-5-Methoxypyridin-4-Yl)-7-Methoxy-3-Methylimidazo[4,5-C]Quinolin-2-One
    • Niraparib Tosilate Monohydrate
    Belgium Denmark France Germany Italy The Netherlands +2
Previous Page
1 … 21 22 23 24 25 … 32
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!